LAVA Therapeutics N.V. (NASDAQ: LVTX) reported Q1 EPS of ($0.02), $0.29 better than the analyst estimate of ($0.31). Revenue for the quarter came in at $6.99 million.

For earnings history and earnings-related data on LAVA Therapeutics N.V. (LVTX) click here.